Talk:Ian Read
| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||
| ||||||||||||||||||
Sources of more biographical information
[edit]According to Bloomberg Business, in 2014, Ian C. Read was Chairman, Chief Executive Officer and Chairman of Executive Committee,Pfizer Inc. His total Calculated Compensation was $23,283,048. He was 61. He was "connected to 117 board members in 5 different organizations across 4 different industries."[1]
| name | position | company | compensation 2012 | compensation 2014 |
|---|---|---|---|---|
| Ian C. Read | Chairman, CEO | Pfizer | 2012 | $23,283,048 |
| John C. Martin Ph.D. | Chairman, CEO 2011 | Gilead Sciences Inc | 2012 | $1.6M |
| Paul Bulcke B.E. | Chairman, CEO | Nestlé S.A. | 2012 | SFr.5.7M |
| David S. Taylor | Chairman, CEO | The Procter & Gamble Company | 2012 | $1.7M |
| Alex Gorsky | Chairman, CEO | Johnson & Johnson | 2012 | $1.5M |
| Joseph Jimenez Jr., MBA | Chairman, CEO | Novartis AG | 2012 | SFr.6.1M |
- *December 5, 2010 Read has been the Chief Executive Officer of Pfizer Inc.[1]
- Mr. Read served as the President of Pfizer Inc. from December 5, 2010 to December 12, 2011.[1]
- Read is the Chairman and Chief Executive Officer at Thiakis Limited. [1]
- He served as Group President of Worldwide Biopharmaceutical Businesses at Pfizer Inc., since October 2009.[1]
- Mr. Read served as Senior Vice President of Pfizer Inc. from August 2006 to December 5, 2010.[1]
- He served as President of Worldwide Pharmaceutical Operations at Pfizer Inc. from August 2006 to October 2009.[1]
- He joined Pfizer in 1978 and serves as its member of the Executive Leadership Team.[1]
- He is responsible for Pfizer's global worldwide pharmaceutical business. As his career progressed he gained significant international experience. He has held various positions of increasing responsibility in pharmaceutical operations.[1]
- He served as an Area President of Europe, Canada, Africa and Middle East, Senior Vice President of the Pfizer Pharmaceuticals Group, and Executive Vice President of Europe and Canada. [1]
- Read served as President of the Latin American region and served as Corporate Vice President of Pfizer Inc., since April 2001.[1]
- He has been the Chairman of Pfizer Inc. since December 12, 2011 and has been its Director since December 5, 2011.[1]
- He has been a Director at Kimberly-Clark Corporation since August 15, 2007.[1]
- He serves as a Director of The Partnership for New York City, Inc. [1]
- He serves as a Director at pharmaceutical Research and Manufacturers of America (PhRMA).[1]
- Mr. Read is Pfizer's representative on the International Section Executive Committee of PhRMA and former chair of the Europe Committee.[1]
- He has served as a Director of both the Brazilian Anglo American Pharmaceutical Association (CIFAB) and the Brazilian Association of the Pharmaceutical Industry (ABIFARMA).[1]
- Mr. Read served as chairman of PhRMA's Latin America Regional Committee (LARC) and vice chairman of the Intellectual Property Coordination Committee (IPCC) section of IFPMA.[1]
- He holds a BSc. degree in Chemical Engineering from London University Imperial College in 1974.[1]
- He earned the Chartered Accountants Certification from the Institute of Chartered Accountants of England and Wales in 1978."[1]